These key drivers, including p53 and Rb inactivation as well as MYC, RAS, Akt-mTOR overactivation, are not only sufficient, but also necessary for NSCLC formation and progression [32–34]. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.